Statistical explanations for a community-based study of once-weekly epoetin alfa therapy in patients receiving chemotherapy

被引：2

作者：

Gabrilove, JL ^{[1
]}

Sarokhan, B

Cremieux, P

机构：

[1] CUNY, Mt Sinai Med Ctr, New York, NY 10029 USA

[2] Ortho Biotech Prod, LP, Raritan, NJ USA

[3] Anal Grp Econ, Cambridge, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 11期

关键词：

D O I：

10.1200/JCO.2002.20.11.2757

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2757 / 2758

页数：2

共 50 条

[41] Hematologic response to epoetin alfa in anemic HIV-positive patients: Once-weekly (QW) dosing similar to three-times weekly (TIW) dosing.
Levine, AM
Saag, M
BLOOD, 1999, 94 (10) : 16B - 16B
[42] Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study
Aapro, Matti
Leonard, Robert C.
Barnadas, Agusti
Marangolo, Maurizio
Untch, Michael
Malamos, Nikolaos
Mayordomo, Jose
Reichert, Dietmar
Luiz Pedrini, Jose
Ukarma, Lidia
Scherhag, Armin
Burger, Hans-Ulrich
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 592 - 598
[43] Predicting clinical outcome of epoetin alfa therapy by tumor type in anemic cancer patients receiving chemotherapy
Glaspy, J
Balaisius, J
Sarokhan, B
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1030 - 1030
[44] Once-weekly epoetin beta treatment is effective in patients with solid tumors-results from the German surveillance study
Kleeberg, Ulrich R.
ANNALS OF ONCOLOGY, 2006, 17 : 295 - 295
[45] Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trial
Vincent, JL
Spapen, HDMH
Creteur, J
Piagnerelli, M
Hubloue, I
Diltoer, M
Roman, A
Stevens, E
Vercammen, E
Beaver, JS
CRITICAL CARE MEDICINE, 2006, 34 (06) : 1661 - 1667
[46] A phase IV study of Epoetin alfa examining clinical outcomes in anaemic cancer patients receiving chemotherapy
Glaspy, J
Bukowski, R
Steinberg, D
Taylor, CW
VadhanRaj, S
Danna, RP
Sarokhan, B
Lonczak, L
McNeill, M
EUROPEAN JOURNAL OF CANCER, 1995, 31A : 233 - 233
[47] Early treatment of mild anemia with once-weekly epoetin alfa significantly improves hemoglobin and quality of life in early-stage breast cancer patients during conventional adjuvant chemotherapy.
Hudis, CA
Williams, D
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S154 - S154
[48] Predicting clinical outcome of Epoetin alfa therapy by tumor type in anemic cancer patients receiving chemotherapy.
Glaspy, J
BLOOD, 1996, 88 (10) : 3285 - 3285
[49] Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy
Meadowcroft, AM
Gilbert, CJ
Maravich-May, D
Hayward, SL
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (18) : 1898 - 1902
[50] Once-weekly recombinant human erythropoetin (epoetin alfa) facilitates optimal ribavirin (RBV) dosing in hepatitis C virus (HCV)-infected patients receiving interferon-α-2b (IFN)/RBV combination therapy
Dieterich, DT
Wasserman, R
Brau, N
Hassanein, TI
Bini, EJ
Sulkowski, M
GASTROENTEROLOGY, 2001, 120 (05) : A64 - A64

← 1 2 3 4 5 →